Email Updates
Commentary
Dangerous deception--hiding the evidence of adverse drug events.
November 29, 2006
Avorn J. N Engl J Med. 2006;355(21):2169-71.
This commentary discusses the recent controversy regarding adverse events associated with several commonly prescribed drugs such as rofecoxib and aprotinin, and recommends publicly funded evaluations of drug safety in order to prevent patient harm.
